These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8080723)

  • 21. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
    Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.
    McKeage MJ; Abel G; Kelland LR; Harrap KR
    Br J Cancer; 1994 Jan; 69(1):1-7. PubMed ID: 8286188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitor.
    Perez RP; Handel LM; Hamilton TC
    Gynecol Oncol; 1992 Jul; 46(1):82-7. PubMed ID: 1634144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatin.
    McClay EF; Jones JA; Winski PJ; Albright KD; Christen RD; Howell SB
    Cancer Res; 1996 Sep; 56(17):3993-7. PubMed ID: 8752169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents.
    Smellie M; Kelland LR; Thurston DE; Souhami RL; Hartley JA
    Br J Cancer; 1994 Jul; 70(1):48-53. PubMed ID: 8018540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circumvention of doxorubicin resistance in multi-drug resistant human leukaemia and lung cancer cells by the pure antioestrogen ICI 164384.
    Hu XF; Nadalin G; De Luise M; Martin TJ; Wakeling A; Huggins R; Zalcberg JR
    Eur J Cancer; 1991; 27(6):773-7. PubMed ID: 1648945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro interactions between platinum analogues in human ovarian-carcinoma cell lines.
    Perez RP; Perez KM; Handel LM; Hamilton TC
    Cancer Chemother Pharmacol; 1992; 29(6):430-4. PubMed ID: 1568285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell lines.
    Zalcberg JR; Hu XF; Ching M; Wakeling A; Wall DM; Marschner IC; de Luise M
    Cancer Chemother Pharmacol; 1993; 33(2):123-9. PubMed ID: 7903222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.
    Bonavida B; Tsuchitani T; Zighelboim J; Berek JS
    Gynecol Oncol; 1990 Sep; 38(3):333-9. PubMed ID: 2227544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationships between resistance to cisplatin and antifolates in sensitive and resistant tumour cell lines.
    Kelland LR; Kimbell R; Hardcastle A; Aherne GW; Jackman AL
    Eur J Cancer; 1995 Jun; 31A(6):981-6. PubMed ID: 7646933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationally designed analogues of tamoxifen with improved calmodulin antagonism.
    Hardcastle IR; Rowlands MG; Houghton J; Parr IB; Potter GA; Jarman M; Edwards KJ; Laughton CA; Trent JO; Neidle S
    J Med Chem; 1995 Jan; 38(2):241-8. PubMed ID: 7830266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
    Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
    J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
    Viale M; Pastrone I; Pellecchia C; Vannozzi MO; Cafaggi S; Esposito M
    Anticancer Drugs; 1998 Jun; 9(5):457-63. PubMed ID: 9660544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH; Lewis AD; Ehsan MN; Sikic BI
    Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro.
    Trendowski M; Christen TD; Acquafondata C; Fondy TP
    BMC Cancer; 2015 Sep; 15():632. PubMed ID: 26357852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein.
    Cole SP; Downes HF; Slovak ML
    Br J Cancer; 1989 Jan; 59(1):42-6. PubMed ID: 2569325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.
    Holford J; Sharp SY; Murrer BA; Abrams M; Kelland LR
    Br J Cancer; 1998; 77(3):366-73. PubMed ID: 9472630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic reversal of drug resistance in ovarian cancer.
    Ozols RF
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):7-11. PubMed ID: 4048979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.